Radiofrequency Ablation of Barrett’s Esophagus: Let’s Not Get Ahead of Ourselves

Falk, Gary W.

doi:10.1007/s10620-010-1292-4

Cited by 5 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent opinion articles and editorials have argued both that all BE should be ablated [21] and the opposing view that it is premature to ablate all BE in all patients [22]. What is agreed is that prospective, randomized, controlled trials of ablation of nondysplastic BE are lacking.…”

Section: Why Ablate Barrett's Esophagus?mentioning

confidence: 99%

Ablative Therapies for Barrett’s Esophagus

Garman

Shaheen²

2011

Curr Gastroenterol Rep

View full text Add to dashboard Cite

Barrett's esophagus has gained increased clinical attention because of its association with esophageal adenocarcinoma, a cancer with increasing incidence and poor survival rates. The goals of ablating Barrett's esophagus are to decrease esophageal cancer rates and to improve overall survival and quality of life. Different techniques have been developed and tested for their effectiveness eradicating Barrett's epithelium. This review assesses the literature associated with different ablative techniques. The safety and efficacy of different techniques are discussed. This review concludes with recommendations for the clinician, including specific strategies for patient care decisions for patients with Barrett's esophagus with varying degrees of dysplasia.

show abstract

Section: Why Ablate Barrett's Esophagus?mentioning

confidence: 99%

Ablative Therapies for Barrett’s Esophagus

Garman

Shaheen²

2011

Curr Gastroenterol Rep

View full text Add to dashboard Cite

show abstract

Update on Ablation for Barrett’s Esophagus

Falk

2013

Curr Gastroenterol Rep

View full text Add to dashboard Cite

Endoscopic ablation has dramatically changed the treatment algorithm for patients with Barrett's esophagus. Studies clearly show the benefits of this approach for patients with high-grade dysplasia and intramucosal carcinoma. Recent studies also provide evidence in support of this approach for patients with low-grade dysplasia but not for patients with nondysplastic Barrett's epithelium. Endoscopic ablation is safe and efficacious in most but not all patients and disease progression may occur during initial therapy as well as after successful completion in a small difficult to identify subset of patients. Furthermore, the past year has provided us with a better understanding of the durability of endoscopic ablation with highly variable rates of disease recurrence. Studies are underway to help determine predictors of response and recurrence.

show abstract

Endoscopic Therapy of Barrett Esophagus

Gaddam

Wani

2013

Gastrointestinal Endoscopy Clinics of North America

View full text Add to dashboard Cite

Radiofrequency Ablation of Barrett’s Esophagus: Let’s Not Get Ahead of Ourselves

Cited by 5 publications

References 28 publications

Ablative Therapies for Barrett’s Esophagus

Ablative Therapies for Barrett’s Esophagus

Update on Ablation for Barrett’s Esophagus

Endoscopic Therapy of Barrett Esophagus

Contact Info

Product

Resources

About